- Advocacy in Action: EDCs in Europe, E/M Codes, Diabetes Test Strips and more...
- Q&A: Clifford Rosen, MD: Practice Guideline on Pharmacological Treatment of Osteoporosis in Post-Menopausal Women.
- Endocrine Reviews Editor-in-Chief, Daniel J. Drucker, MD, Named 2019 Hamm Prize Laureate
- Dust in the Wind: How Chemicals in Dust Promote Fat Cell Development in Kids—A discussion of her research of tumor suppressor genes, endocrine neoplasias, and why an accurate family history is so important to determine when a cancer screening should be performed.
- Gaining Ground, Losing Weight—According to recent studies published in The Journal of Clinical Endocrinology & Metabolism, researchers are getting a better understanding of obesity and the continuing efforts to combat it.
Join us at Clinical Endocrinology Update (CEU) to keep your practice up-to-date. This year's comprehensive program will provide you with the latest advances and critical issues in clinical endocrinology. This year's program highlights include:
- Drug Holidays: What Patients and What Drugs?
E. Michael Lewiecki, MD (Miami); Joy N. Tsai, MD (Seattle) - What's New in Obesity Treatment?
Donna H. Ryan, MD - Safety of Novel Agents in Type 2 Diabetes Management
Carol Wysham, MD - Prolactinomas: Special Topics
Mark E. Molitch, MD (Miami); Lawrence Katznelson, MD (Seattle) - Clinical Update on Thyroid and Pregnancy
Elizabeth N. Pearce, MD, MSc
View the full CEU Miami Program | View the full CEU Seattle Program
Endocrine Board Review (EBR) is a case-based course and mock exam that serves as an excellent knowledge assessment. This course is ideal for endocrine fellows planning to take the endocrine board exam, practicing physicians preparing to re-certify, and also for those seeking an intensive knowledge assessment. View the full EBR Program.
In our most recent episode, we continue our special Women in Endocrinology series with a discussion with Rebecca Simmons, MD, on her Endocrinology article about islet dysfunction in intrauterine growth restriction.
Tune into our podcast to stay up-to-date on the latest advances in endocrinology.
Claim CME and MOC Credits with Ease
Please provide your feedback, complete the evaluation and claim your credits or print your certificate of attendance online at the Center for Learning.
NOD1: An Interface Between Innate Immunity and Insulin Resistance
We have discussed the evidence linking nucleotide-binding oligomerization domain (NOD)1, an intracellular pattern recognition receptor, to the onset and progression of obesity-induced insulin resistance.
The IPL levels were lower in BWA than WE men with early T2D, and the lack of inverse association with first-phase ISF in BWA men indicates that IPL might be a less important determinant of the development of T2D in BWA than in WE men.
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
This review summarizes the present knowledge on genetic and epigenetic alterations.
Through our targeted DSD panel we have identified two variants in the prodomain of BMP7 in hypospadias.